Boji Medical Technology Co.,Ltd. (SHE:300404)

Market Cap	4.15B +21.9%
Revenue (ttm)	949.94M +33.1%
Net Income	43.05M +166.4%
EPS	0.11 +165.4%
Shares Out	383.20M
PE Ratio	96.54
Forward PE	n/a
Dividend	0.01 (0.11%)
Ex-Dividend Date	Jul 15, 2025

Volume	15,776,420
Average Volume	12,834,272
Open	11.02
Previous Close	11.14
Day's Range	10.80 - 11.08
52-Week Range	8.11 - 13.15
Beta	0.30
RSI	65.08
Earnings Date	Apr 25, 2026

About Boji Medical Technology

Boji Medical Technology Co.,Ltd. provides professional contract research services for research and development, and production of drugs and medical devices to pharmaceutical enterprises in China and internationally. It offers pre-clinical research, clinical research, and other consulting services. The company also provides clinical drug production, pilot test scale-up, process verification batch production, and drug registration and approval services. In addition, it engages in the screening, evaluation, verification, and trading of technologic...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1998
• Employees: 1,205
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300404

Financial Performance

In 2025, Boji Medical Technology's revenue was 868.64 million, an increase of 17.06% compared to the previous year's 742.02 million. Earnings were 30.49 million, an increase of 5.97%.